ClinicalTrials.Veeva

Menu

Validation of Hemorrhoidal Bleeding Score

F

Fondation Hôpital Saint-Joseph

Status

Completed

Conditions

Hemorrhoid Bleeding

Study type

Observational

Funder types

Other

Identifiers

NCT03060616
SCORE_SG-hémorroide

Details and patient eligibility

About

The principal manifestation of hemorrhoidal disease is bleeding; however the severity evaluation is today based on prolapsus (Goligher classification) and bleeding factor is not included.

Even if there was some rare score including bleeding in literature , none of them were validated.

The aim of the study is first validation of bleeding score .

Enrollment

130 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age>18 years
  • consulting for hemorroidal bleeding
  • accept to participate

Exclusion criteria

  • paraplegic or hemiplegic patient
  • Misunderstanding of the French language

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems